Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|March 10, 2026
AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodelingChuan Liu, Chuan Hu, Jinlin Cheng, et al.
Cell|December 10, 2025
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapyYan Xu, Xiaoge Zhang, Xiao Han, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 29, 2025
Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8<sup>+</sup> T cell activation in patients with advanced colorectal cancerBin Li, Xudong Zhu, Jingyu Ge, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 3, 2024
Pan-Cancer Single-Cell and Spatial-Resolved Profiling Reveals the Immunosuppressive Role of APOE+ Macrophages in Immune Checkpoint Inhibitor TherapyChuan Liu, Jindong Xie, Bo Lin, et al.
Eclinicalmedicine|September 8, 2023
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trialQihan Fu, Yi Zheng, Weijia Fang, et al.
Liver Cancer|June 16, 2023
Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular CarcinomaZhenggang Ren, Guoliang Shao, Jie Shen, et al.
The EMBO Journal|December 16, 2021
NKG2D discriminates diverse ligands through selectively mechano-regulated ligand conformational changesJuan Fan, Jiawei Shi, Yong Zhang, et al.
Cancers|October 27, 2022
The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort StudyMifen Chen, Zhenghang Wang, Zimin Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2022
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III TrialShukui Qin, Zhendong Chen, Weijia Fang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
Sodium valproate drives propionylation-mediated epigenetic reprogramming to enhance mesothelin CAR-T cell therapy in solid tumorsJiannan Chen, Wenying Li, Shuai Wang, et al.
Pageof 13